Advertisement
Advertisement
U.S. markets close in 6 hours 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.62-0.36 (-1.64%)
As of 9:53AM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/19/2021
Current
6/30/20213/31/202112/31/20209/30/2020
Market Cap (intraday) 5
1.06B1.37B1.45B1.23B1.12B
Enterprise Value 3
654.37M930.22M1.17B1.04B898.66M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.553.035.337.045.30
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-4.35-22.16-32.50-30.60-23.48

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-4.81%
S&P500 52-Week Change 331.55%
52 Week High 338.49
52 Week Low 317.51
50-Day Moving Average 322.44
200-Day Moving Average 325.20

Share Statistics

Avg Vol (3 month) 3159.81k
Avg Vol (10 day) 388.19k
Shares Outstanding 550.24M
Implied Shares Outstanding 6N/A
Float 829.45M
% Held by Insiders 14.98%
% Held by Institutions 190.90%
Shares Short (Sep 29, 2021) 41.98M
Short Ratio (Sep 29, 2021) 410.96
Short % of Float (Sep 29, 2021) 49.45%
Short % of Shares Outstanding (Sep 29, 2021) 43.94%
Shares Short (prior month Aug 30, 2021) 42.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.79%
Return on Equity (ttm)-48.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -152.86M
Net Income Avi to Common (ttm)-150.3M
Diluted EPS (ttm)-3.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)409.36M
Total Cash Per Share (mrq)8.15
Total Debt (mrq)5.14M
Total Debt/Equity (mrq)1.24
Current Ratio (mrq)32.03
Book Value Per Share (mrq)8.28

Cash Flow Statement

Operating Cash Flow (ttm)-148.3M
Levered Free Cash Flow (ttm)-98.64M
Advertisement
Advertisement